-
Precept Life Sciences
Distance: 2.9 Mi1801 Robert Fulton Drive Ste 350
20191 Reston -
Clinical Technology Transfer Group
Distance: 10.9 Mi6600 Old Chesterbrook Rd
22101 McLean -
Montague David T MD
Distance: 77.0 Mi
22560 Tappahannock -
Summit Health Care, Inc
Distance: 94.4 Mi7130 Glen Forest Dr Ste 101
23226-3754 Richmond -
National Clinical Research, Inc.
Distance: 96.0 Mi1400 Westwood Avenue Ste Suite 109
23227 Richmond
Website Links
Description
Keith E. Saylor, Ph.D., Sc.M., the President and CEO of NeuroScience, Incorporated, received his Ph.D. in Health Psychology from Stanford University and his Master's degree in Public Health from the School of Hygiene and Public Health, Johns Hopkins University. Dr. Saylor is a licensed clinical psychologist (Virginia) who maintains active research and private practices. He is an experienced clinician and researcher with special expertise conducting clinical trial research for new medications for behavioral health. He is either a lead- or co-author on a wide range of publications related to the psychological health of children, adolescents, and adults. He is the principal developer of the Life Participation Scale for ADHD (child and adult versions), which has been used successfully in several large clinical trials to measure improvements in ADHD symptoms not captured by other questionnaires. Dr. Saylor's clinical practice focuses largely on disorders of attention and anxiety -- particularly Obsessive Compulsive Disorder (OCD) and OC spectrum disorders (i.e., body dysmorphic disorder, skin picking, trichotillomania), Attention Deficit Hyperactivity Disorder (ADHD), specific phobias, Social Anxiety Disorder, Panic Disorder, and Generalized Anxiety Disorder. Dr. Saylor specializes in cognitive behavioral therapy (CBT) with a particular emphasis on mindfulness-based cognitive behavioral therapy and mindfulness-based stress reduction. Dr. Saylor completed specialized post-doctoral training in couples therapy and sees a limited number of couples therapy cases. He is a member of the International OCD Foundation (IOCDF), the Association for Behavioral and Cognitive Therapies (ABCT), the Anxiety Disorders Association of America, Children and Adults with Attention Deficity Hyperactivity Disorder (CHADD), the Association for Contextual Behavioral Science, and the American Psychological Association (APA). NeuroScience, Incorporated maintains best-practice standards by using the latest evidence-based therapeutic interventions. Dr. Saylor was the first practitioner in the Washington, DC, metropolitan region to introduce Virtual Reality Therapy (VR). Along with the developers of VR, Dr. Saylor has been featured in articles in Baltimore Magazine, Rudy Maxa's Fearless Traveler, Washingtonian Magazine, the Washington Post, Reader's Digest, Outside Magazine, U.S. News and World Report, American Psychologist, and on NBC4 News with Doreen Gentzler. In 2009, Washingtonian Magazine named Dr. Saylor a "Top Therapist," designating him among "the areas most respected therapists." He was a featured therapist on two episodes of Hoarding: Buried Alive, which aired on TLC and Discovery. Melissa R. Andrews, M.Ed. Melissa R. Andrews, M.Ed., is Executive Vice President and Director of Research at NeuroScience, Incorporated Ms. Andrews successfully initiates and manages all aspects of the clinical trial research process. She has performed clinical ratings and neuropsychological testing for Depression, Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Insomnia, Autism, and Bipolar Disorder since 1996.